CN112717124A - 一种用于治疗中老年疾病的中药组合物及其制备方法 - Google Patents
一种用于治疗中老年疾病的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN112717124A CN112717124A CN202110277609.3A CN202110277609A CN112717124A CN 112717124 A CN112717124 A CN 112717124A CN 202110277609 A CN202110277609 A CN 202110277609A CN 112717124 A CN112717124 A CN 112717124A
- Authority
- CN
- China
- Prior art keywords
- parts
- ginseng
- aged
- treating
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 43
- 201000010099 disease Diseases 0.000 title claims abstract description 36
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 43
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 37
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 34
- 229920002101 Chitin Polymers 0.000 claims abstract description 28
- 241001494479 Pecora Species 0.000 claims abstract description 27
- 210000002826 placenta Anatomy 0.000 claims abstract description 26
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 25
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 22
- 241001676573 Minium Species 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims description 29
- 102000008186 Collagen Human genes 0.000 claims description 23
- 108010035532 Collagen Proteins 0.000 claims description 23
- 229920001436 collagen Polymers 0.000 claims description 23
- 238000002386 leaching Methods 0.000 claims description 21
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 20
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 20
- 239000011435 rock Substances 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 18
- 238000000227 grinding Methods 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 235000008434 ginseng Nutrition 0.000 claims description 15
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 239000008213 purified water Substances 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 23
- 206010020772 Hypertension Diseases 0.000 abstract description 16
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 9
- 230000001105 regulatory effect Effects 0.000 abstract description 9
- 210000004204 blood vessel Anatomy 0.000 abstract description 8
- 201000001421 hyperglycemia Diseases 0.000 abstract description 8
- 206010028980 Neoplasm Diseases 0.000 abstract description 7
- 210000004072 lung Anatomy 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 4
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 238000005054 agglomeration Methods 0.000 abstract description 3
- 230000002776 aggregation Effects 0.000 abstract description 3
- 238000011161 development Methods 0.000 abstract description 3
- 229940126678 chinese medicines Drugs 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 4
- 241000180649 Panax notoginseng Species 0.000 description 4
- 235000003143 Panax notoginseng Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 206010046996 Varicose vein Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000000157 blood function Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000009084 cardiovascular function Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000036487 Arthropathies Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 241001022083 Flemingia Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 206010056342 Pulmonary mass Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- -1 nucleic acid compounds Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002903 organophosphorus compounds Chemical class 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Developmental Biology & Embryology (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Hospice & Palliative Care (AREA)
- Reproductive Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
Abstract
一种用于治疗中老年疾病的中药组合物,涉及中药技术领域,其原料包括洋参,人参,粉丹,田七等,通过多种中药材的配比,可以达到软化血管、调节三高的作用,对于由高血脂、高血糖、高血压引起的并发症均有较佳的防治效果。此外,配方中的甲壳素还可以抑制肿瘤的发展,羊胎素还可以抑制肺结块,进一步保障中老年人的身体健康。本发明还提供一种上述用于治疗中老年疾病的中药组合物的制备方法,其操作简单方便,对设备要求不高,可以用于上述用于治疗中老年疾病的中药组合物的快速、规模化生产。
Description
技术领域
本发明涉及中药技术领域,具体而言,涉及一种用于治疗中老年疾病的中药组合物及其制备方法。
背景技术
随着人年龄的增长,身体各项机能会逐渐衰退,代谢水平会逐渐下降,免疫力低下,各种疾病随之而来,给中老年人群带来痛苦,并严重降低其生活质量。
常见的中老年疾病包括高血压、高血脂、冠心病、脑中风、糖尿病、支气管哮喘、慢性支气管炎、慢性胃炎、老年痴呆症、胰腺炎、女性更年期综合征、肝硬化、乳腺癌、食管癌等28种,如不加以重视,极容易耽搁病情,导致严重后果。
发明内容
本发明的目的在于提供一种用于治疗中老年疾病的中药组合物,其配方搭配科学合理,具有软化血管、调节三高的作用,对于由高血脂、高血糖、高血压引起的并发症均有较佳的防治效果。
本发明的另一目的在于提供一种上述用于治疗中老年疾病的中药组合物的制备方法,其操作简单方便,对设备要求不高,可以用于上述用于治疗中老年疾病的中药组合物的快速、规模化生产。
本发明的实施例是这样实现的:
一种用于治疗中老年疾病的中药组合物,按照重量份数计,其原料包括:
洋参10~40份,人参30~100份,本丹15~25份,田七15~25份,羊胎素20~40份,甲壳素45~80份,胶原蛋白10~30份,以及岩豆2~10份。
一种上述用于治疗中老年疾病的中药组合物的制备方法,其包括:
将洋参、人参、本丹、田七、岩豆粉碎后混合研磨,得到粉体;
将粉体加水浸提1~3次,过滤,合并提取液,浓缩干燥,得到药物提取物;
将药物提取物与羊胎素、甲壳素、胶原蛋白混合。
本发明实施例的有益效果是:
本发明实施例提供了一种用于治疗中老年疾病的中药组合物,其原料包括洋参,人参,粉丹,田七等,通过多种中药材的配比,可以达到软化血管、调节三高的作用,对于由高血脂、高血糖、高血压引起的并发症均有较佳的防治效果。此外,配方中的甲壳素还可以抑制肿瘤的发展,羊胎素还可以抑制肺结块,进一步保障中老年人的身体健康。本发明还提供一种上述用于治疗中老年疾病的中药组合物的制备方法,其操作简单方便,对设备要求不高,可以用于上述用于治疗中老年疾病的中药组合物的快速、规模化生产。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚,下面将对本发明实施例中的技术方案进行清楚、完整地描述。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。
下面对本发明实施例的一种用于治疗中老年疾病的中药组合物及其制备方法进行具体说明。
一种用于治疗中老年疾病的中药组合物,按照重量份数计,其原料包括:
洋参10~40份,人参30~100份,粉丹15~25份,田七15~25份,羊胎素20~40份,甲壳素45~80份,胶原蛋白10~30份,岩豆2~10份。
进一步地,按照重量份数计,该原料包括:
洋参20~30份,人参40~70份,本丹20~25份,田七15~20份,羊胎素20~30份,甲壳素45~60份,胶原蛋白20~30份,岩豆5~10份。
更进一步地,按照重量份数计,该原料包括:
洋参25份,人参50份,本丹20份,田七20份,羊胎素30份,甲壳素60份,胶原蛋白20份,岩豆10份。
其中,洋参,为五加科多年生草本植物西洋参的干燥根。性寒,味苦、微甘,具有补气养阴,清火生津之功效,主治烦渴少气,口干舌燥,喘咳痰血等。可以调节身体免疫力、改善心血管功能、改善血液功能、消除自由基、强壮身体。
人参,为五加科植物人参的干燥根。性平,味甘、微苦,具有大补元气,复脉固脱,补脾益肺,生津,安神之功效,主治体虚欲脱,肢冷脉微,脾虚食少便溏,气短乏力,肺虚喘咳,津伤口渴,内热消渴,久病虚羸,惊悸失眠,阳痿宫冷,心力衰竭,心原性休克等。并且可以起到调节免疫力、抗衰老、抗菌、促进新陈代谢、抗肿瘤、改善心血管功能、改善血液功能、改善记忆力的效果。
粉丹,为牡丹的树皮。性微寒,味苦、辛,具有清热凉血、活血散淤之功效。主治温病热入营血所致斑疹、吐血、衄血者,以及血瘀所致经闭痛经、癥瘕积聚等。同时,其具有增强免疫力、降血压、抗炎、保肝等效用。
田七,又称三七,为五加科植物三七的干燥根。性温,味辛、甘、微涩、微苦。具有化瘀止血,消肿止痛之功效,主治内外出血,跌打损伤,瘀血肿痛。同时,其还具有增强免疫力、抗衰老、抗肿瘤、保肝、造血等效用。
羊胎素,羊胎素是从羊胎盘中提出出来的生化活性物质,其含有免疫球蛋白和延缓衰老因子,他们是具有很高应用价值的酶和干扰素。另外羊胎素中蛋白质的含量在80%以上,氨基酸含量丰富,种类齐全,配比合理,脂肪含量小于10%,还含有丰富的卵磷脂,脑磷脂,脂多糖,多种维生素和微量元素,此外,还有转移因子,蛋白质活性因子,胶原蛋白素,有机磷复合物,羊膜酸和核酸化合物等。羊胎素能够调节人体内分泌,调节平衡荷尔蒙,增加血液制造,提高人体免疫力,延缓衰老,还可以抗肿瘤,抑制肺节块。
甲壳素,又称甲壳素、几丁质,是一种从海洋甲壳类动物的壳中提取出来的多糖物质。甲壳素可以通过活化人体免疫系统,从而表现出对肿瘤细胞的抑制作用。同时,甲壳素对于降血脂、降血糖也有一定的功效。
胶原蛋白,胶原蛋白是生物高分子,动物结缔组织中的主要成分,也是哺乳动物体内含量最多、分布最广的功能性蛋白,富含人体所需要的甘氨酸、脯氨酸、羟脯氨酸等氨基酸。胶原蛋白不仅可以维持人体器官的功能,预防疾病,预防骨质疏松,并且还可以增加血管弹性,维持血管的健康,预防血管破裂、栓塞等症状。
岩豆,为豆科植物水边千斤拔的根、茎、叶,性温,味苦。具有祛风除湿,活血止痛之功效。常用于风湿痹痛,关节不利,脾虚白带,慢性阑尾炎。
以上药材经过发明人的精心搭配后,按照特定的比例进行组合,使得各成分之间的药性得以充分发挥,起到协同增效的作用,从而达到软化血管,调节三高的效果,同时,其对于肿瘤、肺节块等具有较佳的抑制效果。非常适用于身体机能逐渐衰退的中老年群体使用。
除此之外,本发明实施例还提供了一种上述用于治疗中老年疾病的中药组合物的制备方法,其包括:
S1. 将洋参、人参、本丹、田七、岩豆粉碎后混合研磨,得到粉体;
S2. 将粉体加水浸提1~3次,过滤,合并提取液,浓缩干燥,得到药物提取物;
S3. 将药物提取物与羊胎素、甲壳素、胶原蛋白混合。
将洋参、人参、本丹、田七、岩豆加工研磨粉体,可以加大其与水的接触面积,使得其药用成分能够更好地被提取出来。优选地,粉体的粒度为10~100目。
进一步地,进行浸提时,粉体和纯净水。浸提的温度为90~105℃,每次浸提的时间为40~60 min。在上述条件下,对于药材中药用成分的提取效果较好,可以提高该中药组合物的药效。
此外,发明人将羊胎素、甲壳素、胶原蛋白在提取完成后再加入,可以有效避免上述成分被高温所破坏,更好地保持上述成分的活性。
以下结合实施例对本发明的特征和性能作进一步的详细描述。
实施例1
本实施例提供了一种用于治疗中老年疾病的中药组合物,按照重量份数计,其原料包括:
洋参10份,人参100份,粉丹15份,田七25份,羊胎素20份,甲壳素45份,胶原蛋白30份,岩豆10份。
其制备方法包括:
S1. 将洋参、人参、粉丹、田七、岩豆粉碎后混合研磨,得到粉体;
S2. 将粉体加水浸提3次,粉体和纯净水。浸提的温度为90~105℃,每次浸提的时间为40~60 min。提取完成后,过滤,合并提取液,浓缩干燥,得到药物提取物;
S3. 将药物提取物与羊胎素、甲壳素、胶原蛋白混合。
实施例2
本实施例提供了一种用于治疗中老年疾病的中药组合物,按照重量份数计,其原料包括:
洋参40份,人参30份, 粉丹15份,田七25份,羊胎素40份,甲壳素80份,胶原蛋白10份,岩豆加工研磨粉体2份。
其制备方法包括:
S1. 将洋参、人参、粉丹、田七、岩豆粉碎后混合研磨,得到粉体;
S2. 将粉体加水浸提2次,粉体和纯净水。浸提的温度为90~105℃,每次浸提的时间为40~60 min。提取完成后,过滤,合并提取液,浓缩干燥,得到药物提取物;
S3. 将药物提取物与羊胎素、甲壳素、胶原蛋白混合。
实施例3
本实施例提供了一种用于治疗中老年疾病的中药组合物,按照重量份数计,其原料包括:
洋参20份,人参40份,粉丹25份,田七20份,羊胎素20份,甲壳素60份,胶原蛋白20份,岩豆加工研磨粉体10份,
其制备方法包括:
S1. 将洋参、人参、粉丹、田七、岩豆粉碎后混合研磨,得到粉体;
S2. 将粉体加水浸提2次,粉体和纯净水。浸提的温度为90~105℃,每次浸提的时间为40~60 min。提取完成后,过滤,合并提取液,浓缩干燥,得到药物提取物;
S3. 将药物提取物与羊胎素、甲壳素、胶原蛋白混合。
实施例4
本实施例提供了一种用于治疗中老年疾病的中药组合物,按照重量份数计,其原料包括:
洋参25份,人参50份,粉丹20份,田七20份,羊胎素30份,甲壳素60份,胶原蛋白20份,岩豆加工研磨粉体5份。
其制备方法包括:
S1. 将洋参、人参、粉丹、田七、岩豆粉碎后混合研磨,得到粉体;
S2. 将粉体加水浸提1次,粉体和纯净水。浸提的温度为90~105℃,每次浸提的时间为40~60 min。提取完成后,过滤,合并提取液,浓缩干燥,得到药物提取物;
S3. 将药物提取物与羊胎素、甲壳素、胶原蛋白混合。
试验例
采用实施例4所提供的用于治疗中老年疾病的中药组合物,在重庆市垫江县先后选择100名试用病患,其中高血压患者34名,高血糖患者38名,高血脂患者28名,每个试用病患每天早晚各服用一剂该中药组合物,每剂该中药组合物由洋参25 g,人参50 g,粉丹20g,田七20 g,羊胎素30 g,甲壳素60 g,胶原蛋白20 g,岩豆5 g的原料制成。用药周期为15日,用药结束后,对试用病患进行回访,试用病患按照药效在0~5分之间进行评分,其中,0分为无效,5分为效果极佳。分数统计结果如表1所示。需要特别说明的是,发明人并不具备在短时间内凑足100名试用病患的能力,该100名试用病患并不是在同一时间测试的,发明人完成100名试用病患的整体测试耗时约3年半。
表1. 用于治疗中老年疾病的中药组合物的药效评分表
试用病患数/人 | 实际回访数/人 | 平均得分 | |
高血压 | 34 | 32 | 4.188 |
高血糖 | 38 | 33 | 3.818 |
高血脂 | 28 | 27 | 3.926 |
由表1可以看出,试用病患中高血压患者共计34人,实际成功回访人数为32人,给出了平均4.188的分数;试用病患中高血糖患者共计38人,实际成功回访人数为33人,给出了平均3.970的分数;试用病患中高血糖患者共计28人,实际成功回访人数为27人,给出了平均4.037的分数。由上表可以看出,试用病患对于该中药组合物的认可度极高,其对于血压、血糖、血脂的调节效果均得到了大家的认可,给出了平均3.8以上的分数,尤其是在对高血压的调节上,给出了4以上的平均分,说明该中药组合物对于血压的调节效果尤为显著。
病例1
曾某某,男,90岁,居住于重庆市垫江县,长期患有静脉曲张,采用本发明实施例4所提供的中药组合物进行治疗15天后痊愈。
病例2
何某某,男,70岁,居住于重庆市垫江县,患有帕金森症,采用本发明实施例4所提供的中药组合物进行治疗1个月后痊愈。
病例3
曾某某,女,75岁,居住于重庆市垫江县,长期患有静脉曲张,采用本发明实施例4所提供的中药组合物进行治疗15天后痊愈。
病例4
胡某某,男,96岁,居住于重庆市垫江县,长期体弱,只能轮椅出行,采用本发明实施例4所提供的中药组合物进行治疗1个月后身体状况明显好转,已可下地步行。
病例5
张某某,男,92岁,居住于重庆市垫江县,患有老年痴呆,采用本发明实施例4所提供的中药组合物进行治疗1个月后状况病情得到控制,并稍有好转。
综上所述,本发明实施例提供了一种用于治疗中老年疾病的中药组合物,其原料包括洋参,人参,粉丹,田七等,通过多种中药材的配伍,可以达到软化血管、调节三高的作用,对于由高血脂、高血糖、高血压引起的并发症均有较佳的防治效果。此外,配方中的甲壳素还可以抑制肿瘤的发展,羊胎素还可以抑制肺结块,进一步保障中老年人的身体健康。本发明还提供一种上述用于治疗中老年疾病的中药组合物的制备方法,其操作简单方便,对设备要求不高,可以用于上述用于治疗中老年疾病的中药组合物的快速、规模化生产。
以上所述仅为本发明的优选实施例而已,并不用于限制本发明,对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (7)
1.一种用于治疗中老年疾病的中药组合物,其特征在于,按照重量份数计,其原料包括:
洋参10~40份,人参30~100份,粉丹15~25份,田七15~25份,羊胎素20~40份,甲壳素45~80份,胶原蛋白10~30份,以及岩豆2~10份。
2.根据权利要求1所述的用于治疗中老年疾病的中药组合物,其特征在于,所述原料包括:
所述洋参20~30份,所述人参40~70份,所述粉丹20~25份,所述田七15~20份,所述羊胎素20~30份,所述甲壳素45~60份,所述胶原蛋白20~30份,以及所述岩豆5~10份。
3.根据权利要求2所述的用于治疗中老年疾病的中药组合物,其特征在于,所述原料包括:
所述洋参25份,所述人参50份,所述本丹20份,所述田七20份,所述羊胎素30份,所述甲壳素60份,所述胶原蛋白20份,以及所述岩豆5份。
4.一种如权利要求1~3任一项所述的用于治疗中老年疾病的中药组合物的制备方法,其特征在于,包括:
将所述洋参、所述人参、所述本丹、所述田七、以及所述岩豆粉碎后混合研磨,得到粉体;
将所述粉体加水浸提1~3次,过滤,合并提取液,浓缩干燥,得到药物提取物;
将所述药物提取物与所述羊胎素、所述甲壳素、所述胶原蛋白混合。
5.根据权利要求4所述的制备方法,其特征在于,所述粉体的粒度为10~100目。
6.根据权利要求4所述的制备方法,其特征在于,进行浸提时,所述粉体和所用水为纯净水;所述粉体和所述水的质量比为1:6~8。
7.根据权利要求4所述的制备方法,其特征在于,浸提的温度为90~105℃,每次浸提的时间为40~60 min。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110277609.3A CN112717124A (zh) | 2021-03-15 | 2021-03-15 | 一种用于治疗中老年疾病的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110277609.3A CN112717124A (zh) | 2021-03-15 | 2021-03-15 | 一种用于治疗中老年疾病的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112717124A true CN112717124A (zh) | 2021-04-30 |
Family
ID=75595849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110277609.3A Pending CN112717124A (zh) | 2021-03-15 | 2021-03-15 | 一种用于治疗中老年疾病的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112717124A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103251814A (zh) * | 2013-05-22 | 2013-08-21 | 陈子良 | 一种调节高血压、高血脂、高血糖的中药制剂 |
CN110464803A (zh) * | 2018-05-09 | 2019-11-19 | 博医生物科技(深圳)股份有限公司 | 一种用于降低血压的中药组合物及其制备方法 |
-
2021
- 2021-03-15 CN CN202110277609.3A patent/CN112717124A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103251814A (zh) * | 2013-05-22 | 2013-08-21 | 陈子良 | 一种调节高血压、高血脂、高血糖的中药制剂 |
CN110464803A (zh) * | 2018-05-09 | 2019-11-19 | 博医生物科技(深圳)股份有限公司 | 一种用于降低血压的中药组合物及其制备方法 |
Non-Patent Citations (8)
Title |
---|
FOREVER栗劲松: "甲壳素是什么?有什么作用?", 《HTTPS://ZHIDAO.BAIDU.COM/QUESTION/1796013443966947147.HTML》, 14 October 2018 (2018-10-14), pages 1 - 3 * |
国家中医药管理局《中华本草》编委会编: "《中华本草 4》", 31 December 1999, pages: 474 * |
李一平,等: "《南方中药材GAP生产加工技术》", 30 April 2003, pages: 289 * |
李勇: "《神经外科常见病诊治进展》", 31 March 2018, pages: 566 - 568 * |
林婷婷,等: "阿尔茨海默病相关药物靶点和临床治疗进展", 《中国科学技术大学学报》, vol. 48, no. 10, 31 October 2018 (2018-10-31), pages 825 - 837 * |
牟宽厚: "胶原蛋白的功效与作用", 《HTTPS://WWW.VODJK.COM/ASK/ASKCONTENT/154557.HTML》, 20 June 2020 (2020-06-20), pages 1 * |
赵紫电,等: "《不动刀的美丽蜕变》", 30 April 2012, pages: 12 * |
都晓伟,等: "从化学和药理学的角度探讨人参、西洋参和三七的传统应用", 《中医药学报》, vol. 33, no. 4, 31 August 2005 (2005-08-31), pages 66 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108324921B (zh) | 一种具有祛除囊肿、保护胃粘膜功能的药物组合物及其制备方法 | |
CN107156820A (zh) | 全面调理女性产后受损体质的营养食品及其制备方法 | |
CN112057501A (zh) | 用于治疗肌肉萎缩与肌无力的中药组合物、中药药膏及外用热敷膏药贴 | |
CN108567914B (zh) | 一种具有改善睡眠作用的中药制剂及其制备方法和应用 | |
CN111647488A (zh) | 一种药食同源补肾酒及其制备方法 | |
CN104474099B (zh) | 一种甜茶止咳露及其制备方法 | |
CN1288168C (zh) | 一种多糖类化合物制剂及制备方法 | |
CN115088849A (zh) | 一种补气养血综合调理的复合低聚阿胶肽制品及制备方法 | |
CN112717124A (zh) | 一种用于治疗中老年疾病的中药组合物及其制备方法 | |
CN111418803A (zh) | 一种养生汤的配制方法 | |
CN112426482A (zh) | 一种调理机体怡心养身的中药组合物和蜜膏及其制备方法 | |
CN112569273A (zh) | 一种抗病毒清热祛火的蒲公英连翘组合物及其制备方法 | |
CN104587300A (zh) | 用于治疗急性白血病的中药组合物及其制备方法 | |
CN117503833B (zh) | 一种食药两用的壮阳补肾中药组合物及其制备方法 | |
CN103610116A (zh) | 一种海参营养胶囊的制造方法 | |
CN109662236A (zh) | 一种富硒多糖多皂苷的食品添加剂、制备方法及其应用 | |
CN108452047B (zh) | 延缓衰老抑制肿瘤细胞生长改善心脑血管微循环的组合物 | |
CN115154548B (zh) | 一种用于增强机体免疫力的中药口服液 | |
CN108813617B (zh) | 一种茸参枸杞组合物及其制备方法 | |
CN116870112B (zh) | 一种治疗变应性鼻炎的中药制剂 | |
CN115025177B (zh) | 一种延缓肌肉衰减的组合物及其制备方法与应用 | |
CN102626471A (zh) | 一种具有防敏脱敏、修复再生作用的中药组合物 | |
CN106109830A (zh) | 一种预防和治疗月子病的中药组合物 | |
CN105687792B (zh) | 预防和治疗心脑血栓疾病的蛭麻胶囊及其制备方法 | |
CN103876213A (zh) | 一种能活血通脉提高免疫力的功能性植物饮料六宝茶 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210430 |